LAL-Ph-2000: Treatment of Acute Lymphoblastic Leukemia Chromosome Philadelphia Positive
Status:
Completed
Trial end date:
2005-04-01
Target enrollment:
Participant gender:
Summary
Due to ALL Ph+ patients should receive a different treatment, is proposed a therapeutical
protocol with: intensification treatment of induction to increment the CR rate, allogenic
transplantation in first CR, autologous transplantation follow by alfa interferon in patients
cannot done allogenic transplantation.